Yi-Ping Lin

Yi-Ping Lin, Ph.D. has a significant amount of experience in the field of quality regulatory and clinical affairs. Yi-Ping currently holds the position of Senior Vice President, Chief Quality Regulatory and Clinical Officer at both Revvity and PerkinElmer, Inc. Prior to this, they served as the Senior Vice President, Quality Regulatory and Clinical Affairs at Cepheid from 2017 to 2023. Before that, they were the Vice President, Quality Assurance and Regulatory Affairs, Molecular Diagnostics at Beckman Coulter from 2014 to 2017. Yi-Ping also held various leadership positions at Abbott Laboratories, Roche Molecular Systems, Johnson & Johnson, and Roche, where they gained extensive experience in quality management and regulatory compliance.

Yi-Ping Lin, Ph.D., completed their education by obtaining a Ph.D. in Biochemistry from Rutgers University from 1986 to 1991.